A case series of children with high-risk metastatic neuroblastoma treated with a novel treatment strategy consisting of postponed primary surgery until the end of systemic chemotherapy including high-dose chemotherapy.

@article{Hashii2008ACS,
  title={A case series of children with high-risk metastatic neuroblastoma treated with a novel treatment strategy consisting of postponed primary surgery until the end of systemic chemotherapy including high-dose chemotherapy.},
  author={Yoshiko Hashii and Takeshi Kusafuka and Hideaki Ohta and Akihiro Yoneda and Yuko Osugi and Yasutsugu Kobayashi and Masahiro Fukuzawa and Junichi Hara},
  journal={Pediatric hematology and oncology},
  year={2008},
  volume={25 5},
  pages={439-50}
}
The aim of this study was to clarify the feasibility of a novel treatment strategy consisting of postponed primary surgery till the end of systemic chemotherapy including HDC without interruption by local therapy for neuroblastoma patients at a high risk for relapse. After induction chemotherapy, patients received double conditioning HDC consisting of… CONTINUE READING